Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Dean, MD
Medical Monitor
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Stanford, California, United States
- Facility name not stated
Stanford, California, United States
- University of Chicago
Chicago, Illinois, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
New Hyde Park, New York, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Rochester, New York, United States
- Facility name not stated
Columbus, Ohio, United States
- Facility name not stated
Springfield, Oregon, United States
- Facility name not stated
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Tyler, Texas, United States
- Fletcher Allen Health Care and University of Vermont
Burlington, Vermont, United States
- Facility name not stated
Vancouver, Washington, United States
- Yakima Valley Memorial Hospital/north Star Lodge
Yakima, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 26 Apr 2019
- Completion
- 26 Apr 2019
- Last update posted
- 27 May 2020
- Registered enrollment
- 199
- Registry id
- NCT01109069
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.